Preview Mode Links will not work in preview mode

May 18, 2024

Featuring perspectives from Ms Jennifer Filipi, Ms Kathryn Lyle, Dr David O’Malley and Dr Shannon N Westin, including the following topics:

  • Introduction (0:00)
  • Incidence and Biology of Endometrial Cancer (EC) (9:30)
  • Use of Immune Checkpoint Inhibitors as Monotherapy for EC (23:24)
  • First-Line Therapy for Primary Advanced or Recurrent EC (28:28)
  • Lenvatinib/Pembrolizumab in the Management of Metastatic EC (1:05:08)
  • Potential Role of Selinexor in the Management of EC (1:13:20)
  • Incidence and Management of HER2-Positive EC (1:22:51)

NCPD information and select publications